Albert Marchio
Vorstandsvorsitzender bei FRESH TRACKS THERAPEUTICS, INC.
Ursprung des Netzwerks ersten Grades von Albert Marchio
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Zoetis Products LLC
 Zoetis Products LLC Pharmaceuticals: MajorHealth Technology Zoetis Products LLC engaged in the manufacturing of pharmaceutical products. The company was founded in 1975 and was headquartered in Florham Park, NJ.
31
| Extinct | Pharmaceuticals: Major | 31 |
Edge Therapeutics, Inc.
 Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ.
21
| Extinct | Biotechnology | 21 |
| Public Company | Pharmaceuticals: Major | 15 | |
| Public Company | Pharmaceuticals: Major | 14 | |
Alpharma LLC
8
| Subsidiary | 8 | |
MedPointe, Inc.
 MedPointe, Inc. Pharmaceuticals: MajorHealth Technology MedPointe, Inc. develops, markets, and sells therapeutics. The company's products include respiratory, allergy, central nervous system, cough/cold, and pediatric products. The company was founded by James S. Burns and Anthony H. Wild in 2001 and is headquartered in Somerset, NJ.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Albert Marchio
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Brickell Subsidiary, Inc.
 Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Brickell Subsidiary, Inc. operates as a clinical-stage pharmaceutical company. It focuses on the development of differentiated, innovative drug therapies for the treatment of skin diseases. The firm specializes in Hyperhidrosis, Cutaneous T-Cell Lymphoma and Psoriasis areas. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in November 2009 and is headquartered in Boulder, CO. | Pharmaceuticals: Major | Director/Board Member Founder Chief Executive Officer Founder Compliance Officer Comptroller/Controller/Auditor | |
| ITERUM THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director/Board Member Founder | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin Doctorate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
| DURATA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Secretary Director of Finance/CFO | |
| New York University | College/University | Graduate Degree Masters Business Admin Masters Business Admin Graduate Degree | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Chairman Corporate Officer/Principal Director/Board Member General Counsel | |
| American University | College/University | Chairman Undergraduate Degree Graduate Degree | |
Iterum Therapeutics International Ltd.
 Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Iterum Therapeutics International Ltd. engages in the development of clinical-stage pharmaceutical products. The company was founded in 2015 and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Iterum Therapeutics US Holding Ltd.
 Iterum Therapeutics US Holding Ltd. Financial ConglomeratesFinance Iterum Therapeutics US Holding Ltd. operates as a clinical-stage pharmaceutical company. The company was founded in 2018 and is headquartered in Chicago, IL. | Financial Conglomerates | Director/Board Member Director/Board Member Director/Board Member | |
| PDS BIOTECHNOLOGY CORPORATION | Pharmaceuticals: Major | General Counsel Director of Finance/CFO Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Notre Dame | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| HONEYWELL INTERNATIONAL INC. | Aerospace & Defense | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Temple University (Pennsylvania) | College/University | Masters Business Admin Graduate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Colorado Boulder | College/University | Masters Business Admin Undergraduate Degree | |
| Villanova University | College/University | Undergraduate Degree Undergraduate Degree | |
EryDel SpA
 EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Medical Specialties | General Counsel Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| ABBOTT LABORATORIES | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| PASSAGE BIO, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Zephyr Ai, Inc.
 Zephyr Ai, Inc. Packaged SoftwareTechnology Services Zephyr Ai, Inc. is a healthcare technology company based in Dallas, TX. Zephyr Ai is committed to revolutionizing drug discovery and precision medicine through partnerships and proprietary data. The company curates the world's most comprehensive healthcare dataset and uses cutting-edge artificial intelligence algorithms to generate novel insights that support patients, providers, and ongoing research. The company was founded in 2020 by Grant Lovely VerStandig, Jeff Sherman, and Yisroel Brumer. David L. Morgan has been the CEO of the company since 2022. | Packaged Software | Director/Board Member Founder | |
| St. Thomas Aquinas College | College/University | Undergraduate Degree Undergraduate Degree | |
Xellia Pharmaceuticals ApS
 Xellia Pharmaceuticals ApS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal | |
| Franklin & Marshall College | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree | |
| HUMANIGEN, INC. | Biotechnology | Chairman Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| CELGENE | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
| MIT Sloan School of Management | College/University | Masters Business Admin Graduate Degree | |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Sales & Marketing | |
| INTERPACE BIOSCIENCES, INC. | Medical Specialties | Director of Finance/CFO Director/Board Member | |
| CARDINAL HEALTH, INC. | Medical Distributors | Corporate Officer/Principal Chief Executive Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| University of Oslo | College/University | Graduate Degree Undergraduate Degree | |
| CERTARA, INC. | Packaged Software | Director/Board Member General Counsel | |
| ARRIVENT BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| BI Norwegian Business School | College/University | Masters Business Admin Undergraduate Degree | |
| Seton Hall University School of Law | College/University | Graduate Degree Graduate Degree | |
QuatRx Pharmaceuticals Co.
 QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology QuatRx Pharmaceuticals Co. manufactures and develops therapeutic compounds. Its clinical products, ospemifene and fispemifene, treat hormone deficiencies that result from aging in women and men. The firm's preclinical program is designed to address sex steroid dependent diseases through inhibition of 17beta- hydroxysteroid dehydrogenase (HSD) enzymes. The company was founded by Robert Zerbe, Christopher Nicholas, and Stuart Dombey on November 20 2000 and is headquartered in Ann Arbor, MI. | Pharmaceuticals: Major | Director/Board Member Founder | |
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistik
International
| Vereinigte Staaten | 42 |
| Irland | 3 |
| Israel | 3 |
| Norwegen | 3 |
| Frankreich | 2 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 15 |
| Finance | 4 |
| Technology Services | 4 |
| Commercial Services | 3 |
Operativ
| Director/Board Member | 380 |
| Corporate Officer/Principal | 204 |
| Independent Dir/Board Member | 127 |
| Chairman | 92 |
| Chief Executive Officer | 72 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| James Healy | 50 |
| Patrick Heron | 42 |
| George Barrett | 33 |
| Liam Ratcliffe | 32 |
| Sol Barer | 32 |
| Anders Hove | 31 |
| Paul Edick | 27 |
| William Jacobs | 24 |
| George W. Rose | 24 |
| Rosemary Crane | 23 |
| Tony H. Wild | 22 |
| Alan Roemer | 21 |
| Joseph Stauffer | 21 |
| Gert Wilhelm Munthe | 21 |
| Gary Lyons | 20 |
- Börse
- Insiders
- Albert Marchio
- Unternehmensverbindungen
